It'll be slower than it would have been without a reduction in supply, but we'll still be able to hit the original targets.
Vaccine yield is always a bit unpredictable, that's the reason targets were relatively conservative to start with, and also part of the reason they weren't bought forward when we've had better than expected supply and rollout.